Liquidity ratios measure the company ability to meet its short-term obligations.
Paying user area
Try for free
Abbott Laboratories pages available for free this week:
- Income Statement
- Statement of Comprehensive Income
- Balance Sheet: Assets
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Reportable Segments
- Enterprise Value (EV)
- Enterprise Value to EBITDA (EV/EBITDA)
- Net Profit Margin since 2005
- Price to Operating Profit (P/OP) since 2005
- Price to Sales (P/S) since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Abbott Laboratories for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Liquidity Ratios (Summary)
Based on: 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).
An analysis of liquidity ratios over the period from March 2022 to March 2026 reveals a general trend of declining liquidity, characterized by an initial period of stability followed by a marked contraction in the final quarters.
- Current Ratio
- The current ratio exhibited an initial peak of 2.01 in June 2022, followed by a period of fluctuation primarily between 1.60 and 1.82. While the ratio remained well above 1.00 for the majority of the observed timeframe, a significant downward trajectory emerged starting in September 2025, culminating in a period low of 1.39 by March 2026.
- Quick Ratio
- The quick ratio followed a similar pattern, peaking at 1.33 in June 2022 before stabilizing near the 1.00 threshold for much of 2023 and 2024. A notable deterioration occurred in the final quarter, where the ratio fell to 0.84, indicating that liquid assets no longer fully cover current liabilities.
- Cash Ratio
- The cash ratio demonstrated a consistent long-term decline. From a high of 0.75 in June 2022, the ratio gradually compressed to the 0.50 range throughout 2024 and 2025. This trend accelerated in the final period, dropping to 0.40 in March 2026, reflecting a reduced reliance on immediate cash reserves relative to short-term obligations.
The synchronized decline across all three metrics suggests a tightening of the overall liquidity position. The convergence of the quick ratio below 1.00 and the sharp drop in the current ratio by March 2026 indicate a shift in the short-term financial structure, resulting in a reduced margin of safety for meeting immediate liabilities.
Current Ratio
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||||||||||||||||||
| Current assets | |||||||||||||||||||||||
| Current liabilities | |||||||||||||||||||||||
| Liquidity Ratio | |||||||||||||||||||||||
| Current ratio1 | |||||||||||||||||||||||
| Benchmarks | |||||||||||||||||||||||
| Current Ratio, Competitors2 | |||||||||||||||||||||||
| Elevance Health Inc. | |||||||||||||||||||||||
| Intuitive Surgical Inc. | |||||||||||||||||||||||
| Medtronic PLC | |||||||||||||||||||||||
| UnitedHealth Group Inc. | |||||||||||||||||||||||
Based on: 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).
1 Q1 2026 Calculation
Current ratio = Current assets ÷ Current liabilities
= ÷ =
2 Click competitor name to see calculations.
The liquidity position experienced a general decline over the observed period, moving from a peak of 2.01 in June 2022 to a period low of 1.39 by March 2026. While the current ratio remained above 1.50 for the majority of the timeline, a notable acceleration in the reduction of this ratio occurred during the final three quarters of the analysis.
- Current Asset Trends
- Current assets exhibited relative stability, fluctuating within a range between US$ 22,376 million and US$ 25,996 million. A gradual recovery in asset levels was observed starting in early 2024, peaking in December 2025 before a slight contraction to US$ 25,508 million in March 2026.
- Current Liability Trajectory
- Current liabilities demonstrated a long-term upward trend, increasing from US$ 12,647 million in March 2022 to a peak of US$ 18,377 million in March 2026. A significant surge in short-term obligations is evident in the final two quarters, where liabilities grew from US$ 14,582 million in September 2025 to US$ 18,377 million by March 2026.
- Current Ratio Analysis
- The current ratio maintained a consistent corridor between 1.60 and 1.80 for the duration of 2023 and most of 2024. However, a sharp deterioration is observed in the final period of the data. The decline from 1.82 in June 2025 to 1.39 in March 2026 indicates that the growth in current liabilities has substantially outpaced the growth in current assets, resulting in a weakened short-term solvency position.
Quick Ratio
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||||||||
| Short-term investments | |||||||||||||||||||||||
| Trade receivables, less allowances | |||||||||||||||||||||||
| Total quick assets | |||||||||||||||||||||||
| Current liabilities | |||||||||||||||||||||||
| Liquidity Ratio | |||||||||||||||||||||||
| Quick ratio1 | |||||||||||||||||||||||
| Benchmarks | |||||||||||||||||||||||
| Quick Ratio, Competitors2 | |||||||||||||||||||||||
| Elevance Health Inc. | |||||||||||||||||||||||
| Intuitive Surgical Inc. | |||||||||||||||||||||||
| Medtronic PLC | |||||||||||||||||||||||
| UnitedHealth Group Inc. | |||||||||||||||||||||||
Based on: 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).
1 Q1 2026 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= ÷ =
2 Click competitor name to see calculations.
The liquidity profile for the period between March 31, 2022, and March 31, 2026, is characterized by a general decline in the quick ratio, shifting from a position of strong short-term coverage to a state where current liabilities exceed quick assets. While the organization maintained a ratio near or above 1.00 for the majority of the observed period, a significant deterioration in liquidity is evident in the final quarter of the analysis.
- Quick Asset Trends
- Total quick assets exhibited moderate volatility, fluctuating between a low of $13.256 billion in March 2024 and a peak of $16.868 billion in December 2025. A period of contraction was observed throughout 2023, followed by a recovery phase through 2024 and 2025. However, this recovery reversed in the first quarter of 2026, with assets declining to $15.505 billion.
- Current Liability Growth
- There is a clear upward trajectory in current liabilities over the analyzed timeframe. Liabilities rose from $12.647 billion in March 2022 to $18.377 billion by March 2026. This represents a substantial increase in short-term obligations, with the most aggressive growth occurring between December 2025 and March 2026, where liabilities increased by approximately $1.88 billion in a single quarter.
- Quick Ratio Interpretation
- The quick ratio peaked at 1.33 in June 2022, indicating a healthy margin of liquidity. For much of 2023 and 2024, the ratio stabilized around the 1.00 to 1.09 range, suggesting that quick assets were roughly equivalent to current liabilities. A critical shift occurred in March 2026, where the ratio dropped to 0.84. This decline is a direct result of the simultaneous increase in current liabilities and the reduction in quick assets, signaling a potential tightening of short-term liquidity and a reduced ability to meet immediate obligations without relying on inventory sales.
Cash Ratio
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||||||||
| Short-term investments | |||||||||||||||||||||||
| Total cash assets | |||||||||||||||||||||||
| Current liabilities | |||||||||||||||||||||||
| Liquidity Ratio | |||||||||||||||||||||||
| Cash ratio1 | |||||||||||||||||||||||
| Benchmarks | |||||||||||||||||||||||
| Cash Ratio, Competitors2 | |||||||||||||||||||||||
| Elevance Health Inc. | |||||||||||||||||||||||
| Intuitive Surgical Inc. | |||||||||||||||||||||||
| Medtronic PLC | |||||||||||||||||||||||
| UnitedHealth Group Inc. | |||||||||||||||||||||||
Based on: 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).
1 Q1 2026 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= ÷ =
2 Click competitor name to see calculations.
The liquidity position exhibits a general downward trend in the cash ratio over the analyzed period, declining from a peak of 0.75 in June 2022 to a period low of 0.40 by March 2026. This contraction suggests a diminishing capacity to settle current liabilities instantaneously using only cash and cash equivalents.
- Cash Asset Trajectory
- Total cash assets experienced initial growth, rising from 8,158 million USD in March 2022 to a peak of 10,170 million USD in December 2022. Following this peak, a period of volatility occurred, with assets dipping to 6,651 million USD by March 2023. While there was a subsequent recovery peaking at 8,939 million USD in December 2025, the final observation in March 2026 shows a decrease to 7,295 million USD.
- Current Liability Expansion
- A consistent upward trajectory is observed in current liabilities. Starting at 12,647 million USD in March 2022, short-term obligations grew steadily, surpassing 18,000 million USD by the final period of March 2026. This sustained increase in liabilities has acted as the primary driver for the deterioration of the cash ratio, as the growth in obligations has outpaced the growth in cash reserves.
- Cash Ratio Correlation and Volatility
- The cash ratio remained relatively stable between 0.47 and 0.56 throughout 2024 and most of 2025, indicating a period of balanced liquidity management. However, a significant drop to 0.40 is noted in March 2026. This decline is the result of a simultaneous decrease in cash assets and a sharp increase in current liabilities, marking the lowest liquidity level within the reported timeframe.